These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24237060)

  • 21. Patent protection for biological inventions--review of recent case law in EEC countries.
    Vossius V
    Eur Intellect Prop Rev; 1979 Oct; 1():278-82. PubMed ID: 11662912
    [No Abstract]   [Full Text] [Related]  

  • 22. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competition policy in patent cases and antitrust.
    Sobel G
    Adv Genet; 2003; 50():23-64; discussion 507-10. PubMed ID: 14714685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patent law--man-made, living microorganisms held patentable subject matter under section 101 of the Patent Act--Diamond v. Chakrabarty, 447 U.S. 303 (1980).
    Faggen N
    Temple Law Q; 1981; 54(2):308-30. PubMed ID: 11652407
    [No Abstract]   [Full Text] [Related]  

  • 25. Patenting medical inventions.
    Schwertner HA
    Mil Med; 1994 Dec; 159(12):729-32. PubMed ID: 7723995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patent law--patent on life form--man-made modification of microorganism is patentable subject matter under 35 U.S.C. 101--Diamond v. Chakrabarty, 100 S.Ct. 2204 (1980).
    Vidas S
    Hamline Law Rev; 1981 Jan; 4(2):341-50. PubMed ID: 11650724
    [No Abstract]   [Full Text] [Related]  

  • 27. Protecting new ideas and inventions in nanomedicine with patents.
    Bawa R; Bawa SR; Maebius SB; Flynn T; Wei C
    Nanomedicine; 2005 Jun; 1(2):150-8. PubMed ID: 17292072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the European Patent Office's approach to assessing obviousness of antibody inventions consistent?
    Rigby B
    Expert Opin Ther Pat; 2014 Dec; 24(12):1283-5. PubMed ID: 25407281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patent survey case: how could technological forecasting help cosmetic chemists with product innovation?
    Domicio Da Silva Souza I; Juliana Pinheiro B; Passarini Takahashi V
    J Cosmet Sci; 2012; 63(6):365-83. PubMed ID: 23286869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent and intellectual property rights related to pharmaceuticals: global future perspectives: Japan.
    Komatani TS
    Pharm Pat Anal; 2016 Jul; 5(4):227-35. PubMed ID: 27334256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell patents after the america invents act.
    Sherkow JS; Scott CT
    Cell Stem Cell; 2015 May; 16(5):461-4. PubMed ID: 25957901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent law: live, human-made microorganisms are patentable subject matter under 35 U.S.C. Sect. 101--Diamond v. Chakrabarty.
    Namei FT
    Univ Cincinnati Law Rev; 1980; 49(4):902-13. PubMed ID: 11650489
    [No Abstract]   [Full Text] [Related]  

  • 34. Patents--patentable subject matter--living man-made organisms held to be patentable subject matter under 35 U.S.C. Section 101.
    Day MT
    Marquette Law Rev; 1980; 63(4):711-30. PubMed ID: 11662894
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to successfully patent therapeutic antibodies.
    Lahrtz F
    J Biomol Screen; 2015 Apr; 20(4):484-91. PubMed ID: 25614506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
    Morelli Gradi G
    Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell patents--reexamination/litigation--the last 5 years.
    Shyntum Y; Kalkreuter E
    Tissue Eng Part B Rev; 2009 Mar; 15(1):87-90. PubMed ID: 19260807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of the evolution of the written description requirement vis-à-vis DNA and biotechnological inventions.
    Greenbaum D
    Recent Pat DNA Gene Seq; 2007; 1(2):138-44. PubMed ID: 19075928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.